tm
Seeing Is Believing
tm
Seeing Is Believing
AQST is currently covered by 5 analysts with an average price target of $10.52. This is a potential upside of $4.31 (69.4%) from yesterday's end of day stock price of $6.21.
Aquestive Therapeutics's activity chart (see below) currently has 96 price targets and 88 ratings on display. The stock rating distribution of AQST is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 23.32% with an average time for these price targets to be met of 180.5 days.
Highest price target for AQST is $12, Lowest price target is $7, average price target is $9.
Most recent stock forecast was given by JASON BUTLER from JMP on 09-Oct-2025. First documented stock forecast 20-Aug-2018.
Currently out of the existing stock ratings of AQST, 8 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 20-Aug-2018
$12
$5.55 (86.05%)
$9
2 months 30 days ago
(09-Oct-2025)
0/11 (0%)
$5.31 (79.37%)
Buy
Since 31-May-2023
$8
$1.55 (24.03%)
$12
4 months ago
(08-Sep-2025)
0/3 (0%)
$2.99 (59.68%)
Buy
Since 22-Apr-2019
$10
$3.55 (55.04%)
$10
6 months 22 days ago
(17-Jun-2025)
9/30 (30%)
$6.65 (198.51%)
323
Buy
Since 31-Jan-2023
$7
$0.55 (8.53%)
$9
7 months 6 days ago
(02-Jun-2025)
6/7 (85.71%)
$4.19 (149.11%)
238
Buy
Since 03-Jan-2019
$8
$1.55 (24.03%)
$10
10 months 1 days ago
(07-Mar-2025)
2/8 (25%)
$5.35 (201.89%)
265
What is AQST (Aquestive Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?
Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?
Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?
